|
 |
|
 |
|
The most current pension and investment information available in Canada, located in these easy to use directories. Click on any logo for information.
|
|
 |
|
 |
|
|
|
|
|
|
 |
|
May 2002
To order the May 2002 issue, or any others, call our single copy
sales department at (416) 596-5038. If you prefer, you may order single issues,
or single articles using the order form on this
site.
|
|
|
|
|
Features
|
Pensions
> Governance in shreds
The Enron case offers important lessons in corporate and pension governance for Canadian plan sponsors.
By John Por
> The Next 25 Years: Group Insurance
The Canadian insurance industry has relied on replicating its competitors and it's worked - so far. In the future, it has to innovate in order to compete globally.
By Ashim Khemani
|
Investments
> This is not the Caisse
CDP Capital is looking to earn third-party mandates. Do they have a shot?
By Kevin Press
|
Benefits
> 2002 Group Insurance Report
The industry is shrinking but insured premiums have grown by 14.9%.
By Kathryn Dorrell
> The drug debate
Many new drugs offer advantages, but how can plan sponsors distinguish between a breakthrough and a me-too medication?
By Gerry Jeffcott
|
Departments
> Editorial
Chip wagons ho!
By Kevin Press
> Insights
The TSX launches anonymous trading.
By Deanna Rosolen
> Viewpoint
Maternity leaves.
By Shelly Shapero and Natasha vandenHoven
> E-poll
Should drug manufacturers be allowed to advertise directly to consumers?
> Investment Strategies
Understanding quantitative strategies.
By Paul Carter
> Benefits Trends
Covering male menopause.
By Kathryn Dorrell
> Pension Planning
The CSA's proposals may offer a false sense of security.
By Glorianne Stromberg
> The Law
Accomodating mental illness.
By Hugh O'Reilly
> Industry
HIV/AIDS at work.
By Deanna Rosolen
> People
> Back Words
Toronto stocks over 25 years.
By Kathryn Dorrell
|
|
|
|
|
|
|
|
News
News
